A series of novel 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives have been synthesized in good to excellent yields. Through the copper-catalyzed azide-alkyne cycloaddition via reaction of 7-(prop-2-ynyl)-7H-pyrrolo[2,3-d]pyrimidine and aryl, heteroaryl and alkyl azides in the presence of CuSO·5HO and sodium ascorbate. These compounds were evaluated for their in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv strain. Most of these pyrrolopyrimidine-triazole hybrids exhibited good anti tubercular activity. The antimycobacterial assay results showed that the minimum inhibitory concentration of compounds 4q and 4r were 0.78 µg/mL. The molecular docking results also had shown highest Moldock score for same compounds. These novel compounds exhibited good inhibition activities and further structure-activity studies of the derivatives had shown promising features to use in antitubercular therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2018.11.036DOI Listing

Publication Analysis

Top Keywords

1h-pyrrolo[23-d]pyrimidine-123-triazole derivatives
8
exhibited good
8
synthesis biological
4
biological evaluation
4
evaluation 1h-pyrrolo[23-d]pyrimidine-123-triazole
4
derivatives novel
4
novel anti-tubercular
4
anti-tubercular agents
4
agents series
4
series novel
4

Similar Publications

Lysine-specific demethylase 1 (LSD1) plays a vital role in the epigenetic regulation of various cancers, making it a promising therapeutic target for anticancer treatments. Herein, we designed and synthesized a novel series of 1-pyrrolo[2,3-]pyridin derivatives as potent LSD1 inhibitors. A detailed structure-activity relationship exploration was carried out to discover multiple derivatives with nanomolar enzymatic IC values.

View Article and Find Full Text PDF

The JAK-STAT signalling pathway is primarily involved in cytokine signalling and induces various factors namely, erythropoietin, thrombopoietin, interferons, interleukins, and granulocyte colony-stimulating factors. These factors tremendously influenced understanding human health and illness, specifically cancer. Inhibiting the JAK/STAT pathway offers enormous therapeutic promises against cancer.

View Article and Find Full Text PDF

It is of great significance to design and synthesize novel structural inhibitors with good antitumor activity. In this study, based on rational design, a total of 42 7-azaindole derivatives as novel CDK8 inhibitors were designed and synthesized. All compounds were screened with antitumor activity and compound 6 (1-(3-((1-pyrrolo[2,3-]pyridin-5-yl)oxy)phenyl)-3-(-tolyl)urea) exhibited the best activity, especially in acute myeloid leukemia (GI MV4-11 = 1.

View Article and Find Full Text PDF

Pyrrolo[2,3-]quinoxaline derivatives are known to possess antioxidant, anticancer, and antibacterial properties. Here we report the successful synthesis of five derivatives of 3-hydroxy-3-pyrroline-2-one through substitution. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay was employed to evaluate the antioxidant activity of the compounds.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to assess how effective and safe JAK inhibitors are for treating patients with rheumatoid arthritis (RA) by analyzing various randomized controlled trials (RCTs).
  • A total of 33 RCTs with 15,961 patients were reviewed, showing that JAK inhibitors generally had significantly better efficacy compared to placebo, with decernotinib ranked highest in effectiveness.
  • While low-dose filgotinib was found to be the safest option, there were no major safety differences among the various JAK inhibitors, highlighting the need for direct head-to-head studies for clearer comparisons.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!